tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

CRMD Stock Latest News

CorMedix price target lowered to $17 from $20 at H.C. Wainwright
The FlyCorMedix price target lowered to $17 from $20 at H.C. Wainwright
3d ago
CRMD
CorMedix Inc. Reports Strong Q2 2025 Results
PremiumCompany Announcements
CorMedix Inc. Reports Strong Q2 2025 Results
3d ago
CRMD
M&A News: CorMedix Stock (CRMD) Plunges 11% Despite $300M Melinta Deal
PremiumMarket News
M&A News: CorMedix Stock (CRMD) Plunges 11% Despite $300M Melinta Deal
3d ago
CRMD
Cormedix’s Strategic Growth Potential Boosted by Melinta Therapeutics Acquisition
PremiumRatings
Cormedix’s Strategic Growth Potential Boosted by Melinta Therapeutics Acquisition
3d ago
CRMD
CorMedix Announces Merger Agreement with Melinta Therapeutics
PremiumCompany Announcements
CorMedix Announces Merger Agreement with Melinta Therapeutics
4d ago
8K
CRMD
CorMedix sees FY25 pro forma revenue $305M-$335M
PremiumThe FlyCorMedix sees FY25 pro forma revenue $305M-$335M
4d ago
CRMD
CorMedix to acquire Melinta Therapeutics for $300M
Premium
The Fly
CorMedix to acquire Melinta Therapeutics for $300M
4d ago
CRMD
CorMedix reports Q2 EPS 28c, consensus 19c
Premium
The Fly
CorMedix reports Q2 EPS 28c, consensus 19c
4d ago
CRMD
CRMD Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
CRMD Earnings Report this Week: Is It a Buy, Ahead of Earnings?
6d ago
CRMD
CorMedix Inc. Advances Pediatric Dialysis Safety with New Clinical Study
PremiumCompany Announcements
CorMedix Inc. Advances Pediatric Dialysis Safety with New Clinical Study
1M ago
CRMD
CorMedix’s DEFENCATH® Study: A Potential Game-Changer in Infection Prevention
PremiumCompany Announcements
CorMedix’s DEFENCATH® Study: A Potential Game-Changer in Infection Prevention
1M ago
CRMD
CorMedix Completes $82.2 Million Stock Offering
PremiumCompany Announcements
CorMedix Completes $82.2 Million Stock Offering
1M ago
8K
CRMD
Circle initiated, Disney upgraded: Wall Street’s top analyst calls
PremiumThe FlyCircle initiated, Disney upgraded: Wall Street’s top analyst calls
1M ago
ED
BAM
CorMedix downgraded to Hold from Buy at D. Boral Capital
Premium
The Fly
CorMedix downgraded to Hold from Buy at D. Boral Capital
1M ago
CRMD
CorMedix initiated with a Buy at H.C. Wainwright
Premium
The Fly
CorMedix initiated with a Buy at H.C. Wainwright
1M ago
CRMD
CorMedix 6.605M share Spot Secondary priced at $12.87
PremiumThe Fly
CorMedix 6.605M share Spot Secondary priced at $12.87
1M ago
CRMD
Closing Bell Movers: Nike gains 10% on more positive earnings call
PremiumThe Fly
Closing Bell Movers: Nike gains 10% on more positive earnings call
2M ago
AB
BEN
CorMedix announces $85M common stock offering
PremiumThe Fly
CorMedix announces $85M common stock offering
2M ago
CRMD
CorMedix’s Promising Growth: Buy Rating Backed by Strong DefenCath Launch and Strategic Partnerships
PremiumRatings
CorMedix’s Promising Growth: Buy Rating Backed by Strong DefenCath Launch and Strategic Partnerships
2M ago
CRMD
CorMedix Holds Annual Stockholders Meeting, Approves Key Proposals
PremiumCompany AnnouncementsCorMedix Holds Annual Stockholders Meeting, Approves Key Proposals
2M ago
8K
CRMD
CorMedix Expands DefenCath Implementation with Major Client
Premium
Company Announcements
CorMedix Expands DefenCath Implementation with Major Client
2M ago
8K
CRMD
CorMedix price target raised to $20 from $15 at Needham
Premium
The Fly
CorMedix price target raised to $20 from $15 at Needham
2M ago
CRMD

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >